Related references
Note: Only part of the references are listed.Sensorineural hearing loss in patients with head and neck cancer after chemoradiotherapy and radiotherapy: A systematic review of the literature
Eleonoor A. R. Theunissen et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2015)
Long-Term Hearing Loss After Chemoradiation in Patients With Head and Neck Cancer
Eleonoor A. R. Theunissen et al.
LARYNGOSCOPE (2014)
Cheyne-Stokes respiration and obstructive sleep apnoea are independent risk factors for malignant ventricular arrhythmias requiring appropriate cardioverter-defibrillator therapies in patients with congestive heart failure
Thomas Bitter et al.
EUROPEAN HEART JOURNAL (2011)
Tinnitus Handicap Inventory for Evaluating Treatment Effects: Which Changes Are Clinically Relevant?
Florian Zeman et al.
OTOLARYNGOLOGY-HEAD AND NECK SURGERY (2011)
Patterns of relapse following definitive treatment of head and neck squamous cell cancer by intensity modulated radiotherapy and weekly cisplatin
Venla Loimu et al.
RADIOTHERAPY AND ONCOLOGY (2011)
Evaluation of Audiometric Threshold Shift Criteria for Ototoxicity Monitoring
Dawn Konrad-Martin et al.
JOURNAL OF THE AMERICAN ACADEMY OF AUDIOLOGY (2010)
RELATIVE CONTRIBUTIONS OF RADIATION AND CISPLATIN-BASED CHEMOTHERAPY TO SENSORINEURAL HEARING LOSS IN HEAD-AND-NECK CANCER PATIENTS
Ying J. Hitchcock et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2009)
Toxicity of two cisplatin-based radiochemotherapy regimens for the treatment of patients with stage III/IV head and neck cancer
Dirk Rades et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2008)
Intensity-modulated radiation therapy in head and neck cancers: An update
Nancy Lee et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2007)
Ototoxicity of cisplatin plus standard radiation therapy vs. accelerated radiation therapy in glioblastoma patients
Nicole E. Marshall et al.
JOURNAL OF NEURO-ONCOLOGY (2006)
Sensorineural hearing loss after radiotherapy and chemoradiotherapy: A single, blinded, randomized study
WK Low et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Sparing of the submandibular glands by intensity modulated radiotherapy in the treatment of head and neck cancer
K Saarilahti et al.
RADIOTHERAPY AND ONCOLOGY (2006)
Decreased hearing after combined modality therapy for head and neck cancer
SE Pearson et al.
AMERICAN JOURNAL OF OTOLARYNGOLOGY (2006)
Audiometric patterns in ototoxicity of intra-arterial cisplatin chemoradiation in patients with locally advanced head and neck cancer
C. L. Zuur et al.
AUDIOLOGY AND NEURO-OTOLOGY (2006)
Intensity modulated radiotherapy for head and neck cancer:: evidence for preserved salivary gland function
K Saarilahti et al.
RADIOTHERAPY AND ONCOLOGY (2005)
Cochlear structure and function after round window application of ototoxins
CA Bauer et al.
HEARING RESEARCH (2005)
Simultaneous radio- and chemotherapy for squamous cell carcinoma of the head and neck in daily clinical practice: 5 years experience in a University Hospital
M Langenberg et al.
CLINICAL OTOLARYNGOLOGY (2004)
Increases in spontaneous neural activity in the hamster dorsal cochlear nucleus following cisplatin treatment: a possible basis for cisplatin-induced tinnitus
JD Rachel et al.
HEARING RESEARCH (2002)
Evoked otoacoustic emissions - an approach for monitoring cisplatin induced ototoxicity in children
P Stavroulaki et al.
INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY (2001)
Dose-dependent effect of 8-day cisplatin administration upon the morphology of the albino guinea pig cochlea
RM Cardinaal et al.
HEARING RESEARCH (2000)
Share Paper
